Annual Drug Patent Expirations for TLANDO
Tlando is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has thirty-three patent family members in fifteen countries.
The generic ingredient in TLANDO is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com